Nj State Employees Deferred Compensation Plan Biogen Inc. Transaction History
Nj State Employees Deferred Compensation Plan
- $877 Million
- Q3 2025
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Biogen Inc. stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 5,180 shares of BIIB stock, worth $805,541. This represents 0.08% of its overall portfolio holdings.
Number of Shares
5,180
Previous 2,500
107.2%
Holding current value
$805,541
Previous $313,000
131.63%
% of portfolio
0.08%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding BIIB
# of Institutions
1,055Shares Held
131MCall Options Held
2.84MPut Options Held
2.55M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.69 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.46 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.26 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.16 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$746 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $22.4B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...